As current therapeutic options for pancreatic cancer are mostly ineffective, developing diagnostic tools for early detection of precursor lesions (mainly pancreatic intraepithelial neoplasia – PanIN) could change the course of this disease. Here, we investigated Diffusion-MRI (dMRI) contrasts for this purpose, using transgenic mouse models. First, we performed ex vivo dMRI Microscopy at ultrahigh field with histological validation, defining the most sensitive contrasts. Then, we performed in vivo abdominal imaging, demonstrating their applicability in the non-invasive study of PanIN and pancreatic cancer. These findings provide new tools for researching PanIN and hold promise for a future translation to clinical practice.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords